MAPT and Alzheimer disease: Data shows that PP1γ, on one hand, regulates neuronal insulin signaling and insulin resistance via AKT2-AS160-GLUT4-glucose uptake arm and AD-like phenomena via AKT2-GSK3β-Tau-NFT arm.